Original Research 
Responses to 2009 H1N1 Vaccine in Children 3 to 17 Years of Age(1)
CORRESPONDENCE
Responses to 2009 H1N1 Vaccine in Children 3 to 17 Years of Age
A. Arguedas, C. Soley, and K. Lindert
These preliminary data support the use of one 15-μg dose of 2009 H1N1 vaccine without adjuvant in children between the ages of 9 and 17 years. However, in children 3 to 8 years of age, only the [...]
Outbreak of 2009 Pandemic Influenza A (H1N1) at a New York City School
ORIGINAL ARTICLE
Outbreak of 2009 Pandemic Influenza A (H1N1) at a New York City School
J. Lessler and Others
Once introduced into a high school in New York City, the 2009 H1N1 virus spread quickly among students and staff, with an influenza-like illness developing in more than 800 people during a 2-week period in April 2009.
Full Text | [...]
Household Transmission of 2009 Pandemic Influenza A (H1N1) Virus in the United States
ORIGINAL ARTICLE
Household Transmission of 2009 Pandemic Influenza A (H1N1) Virus in the United States
S. Cauchemez and Others
This study shows that when a member of the household became infected with the 2009 H1N1 influenza virus, household contacts less than 18 years of age were twice as susceptible to an acute respiratory illness as were those 19 [...]
Pediatric Hospitalizations Associated with 2009 Pandemic Influenza A (H1N1) in Argentina
ORIGINAL ARTICLE
Pediatric Hospitalizations Associated with 2009 Pandemic Influenza A (H1N1) in Argentina
R. Libster and Others
During the winter (May through July 2009) in Buenos Aires, the death rate associated with 2009 H1N1 influenza in children was 10 times that associated with seasonal influenza in 2007.
Full Text | PDF
More in this category
- Intravenous Zanamivir for Oseltamivir-Resistant 2009 H1N1 Influenza
- Severe 2009 H1N1 Influenza in Pregnant and Postpartum Women in California
- A Community Cluster of Oseltamivir-Resistant Cases of 2009 H1N1 Influenza
- Clinical Features of the Initial Cases of 2009 Pandemic Influenza A (H1N1) Virus Infection in China
- Rapid-Test Sensitivity for Novel Swine-Origin Influenza A (H1N1) Virus in Humans
- Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis